| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/28/2006 | US7018610 Poly-L-R-Y, where poly represents a polymer( such as polystyrene homo or copolymer) R= aryl or heteroaryl, L= R3-Sn-R3 (R3= alkyl, alenyl or alkynyl), Y= hydrogen, alkyl, alkoxy, carbonyl, formyl, amido, amino, carobxyamido etc. |
| 03/28/2006 | US7018609 For drug delivery |
| 03/28/2006 | US7018371 Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia |
| 03/23/2006 | WO2006030291A2 Radiofluorinated peptides |
| 03/23/2006 | WO2006030197A2 Radiolabelled insulin |
| 03/23/2006 | WO2005113720A3 A strategy for designing patient-specific anti-cancer drugs |
| 03/23/2006 | WO2005044980A3 Zap protein and related compositions and methods |
| 03/23/2006 | WO2005000250A3 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor |
| 03/23/2006 | WO2004096254A3 Transferrin conjugates for tumor treatment |
| 03/23/2006 | US20060063706 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals; treating infection caused by methicillin-resistant Staphylococcus aureus |
| 03/23/2006 | US20060062729 Enhanced ligand binding to neurotensin receptors |
| 03/23/2006 | US20060062728 Multifunctional cross-bridged tetraaza macrocyclic compounds and methods of making and using |
| 03/23/2006 | US20060062727 Compositions and methods for the diagnosis and treatment of tumor |
| 03/23/2006 | US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies |
| 03/23/2006 | US20060062725 Methods for preparing metal-carborane complexes for radioimaging and radiotherapy |
| 03/23/2006 | DE102004043153A1 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin |
| 03/23/2006 | CA2579900A1 Cancerous disease modifying antibodies |
| 03/23/2006 | CA2578470A1 Method of radiofluorination and radiofluorinated compounds for use in diagnosis or imaging of angiogenesis |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637128A2 Use of simple amino acids to form porous particles |
| 03/22/2006 | EP1635880A2 Microparticles for microarterial imaging and radiotherapy |
| 03/22/2006 | EP1635879A2 Lectin conjugates |
| 03/22/2006 | EP1404319B1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 03/22/2006 | EP0951297B1 Detection of antigens via oligonucleotide antibody conjugates |
| 03/22/2006 | CN1751041A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/22/2006 | CN1246042C Preparation method of therapy used iodine-125 sealed seed source core |
| 03/22/2006 | CN1246041C Solid-phase nucleophilic fluorination |
| 03/21/2006 | US7015306 Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2443314C Method of imaging cell death in vivo |
| 03/16/2006 | WO2006029303A2 Diphenyl ether derivatives and their use for imaging serotonin transporters |
| 03/16/2006 | WO2005084410A9 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 03/16/2006 | WO2005084179A3 Improved method for preparing conjugates of proteins and chelating agents |
| 03/16/2006 | WO2005079867A3 Alpha-emitting hydroxyapatite particles |
| 03/16/2006 | US20060058291 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060057181 Method for determining the gastric evacuation using a 13c-labelled test meal |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057136 Immunotherapy of B-Cell malignancies using anti-CD22 antibodies |
| 03/16/2006 | US20060057064 Useful in SPECT image diagnosis, PET image diagnosis, MRI image diagnosis and the like, for imaging sites of inflammation |
| 03/16/2006 | US20060057063 Therapy of cancer, diagnosis, imaging; drug conjugate; targeting agent and an anti-cancer agent, wherein targeting agent comprises an erythropoietin receptor ligand |
| 03/16/2006 | US20060057062 Compositions and methods useful in pretargeted imaging |
| 03/16/2006 | DE102004035916A1 Device, useful for isotopically determining nitrogen monoxide concentration in e.g. breathing air, comprises a UV source of light (emits a light of wavelength and electronically energizes isotope of nitrogen monoxide) and a light detector |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1633785A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/15/2006 | EP1175388B1 Spect imaging agents for serotonin transporters |
| 03/15/2006 | CN1747749A Diagnostic imaging agents with mmp inhibitory activity |
| 03/15/2006 | CN1747072A Radioactive liquid generating system and heating chamber with dispensing function |
| 03/15/2006 | CN1245156C Methods for in vivo delivery of biologics and compositions therefor |
| 03/14/2006 | US7011816 Complex of gallium-68 with a macrocyclic chelating agent linked via peptidyl spacer to one or more recognition units recognized by a multispecific targeting antibody |
| 03/14/2006 | US7011815 Magnetic resonance imaging; gadofosveset |
| 03/14/2006 | US7011814 Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
| 03/14/2006 | US7011813 Cocaine receptor binding ligands |
| 03/14/2006 | US7011812 Targeted combination immunotherapy of cancer and infectious diseases |
| 03/09/2006 | WO2006026603A2 Improved containers for pharmaceuticals, particularly for use in radioisotope generators |
| 03/09/2006 | WO2006026184A2 Blood brain barrier permeation peptides |
| 03/09/2006 | US20060052654 Carrier-free 103pd brachytherapy seeds |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051293 noninvasive technique for imaging and quantitating amyloid deposits; 2-phenyl- imidazo [1,2,a] pyridine derivatives; radiolabelling; drug delivery; 2-(4'-dimethylaminophenyl)-6-iodobenzothiazole |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | US20060051291 Synthesis of radiolabeled sugar metal complexes |
| 03/09/2006 | US20060051290 Short carbon nanotubes as adsorption and retention agents |
| 03/09/2006 | CA2797666A1 Peptide derivatives of exendin-3 |
| 03/09/2006 | CA2579073A1 Improved containers for pharmaceuticals, particularly for use in radioisotope generators |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1631320A2 Use of a tetrapeptide acsdkp analogue resistant to the angiotensin i conversion enzyme, for measuring glomerular filtration rate in a human or an animal and kit containing same |
| 03/08/2006 | EP1631146A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1280559B1 Acylated cyclodextrin guest inclusion complexes |
| 03/08/2006 | EP1230338B1 Continuous-flow method for preparing microparticles |
| 03/08/2006 | EP1210068B1 Use of simple amino acids to form porous particles |
| 03/08/2006 | EP0771190B1 Lock and key micelles |
| 03/08/2006 | EP0538402B1 Method of preparing a radioactive rhenium complex solution |
| 03/08/2006 | CN1744890A Labeled macrophage scavenger receptor antagonists for imaging cardiovacular diseases |
| 03/07/2006 | US7009040 Administering a monoclonal antibody encoded by a clone on deposit which binds specifically to an antigen expressed by a tumor; screening for cancerous cells; biological conjugation with a radioisotope, enzyme toxins and hematogenous cells; antitumor agents; anticarcinogenic agents; cytotoxicity |
| 03/07/2006 | US7008923 Glycopeptide phosphonate derivatives |
| 03/07/2006 | US7008633 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent |
| 03/07/2006 | US7008613 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 03/02/2006 | WO2006023200A2 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 03/02/2006 | WO2005107387A3 Targeting of radioimagining and radiotherapy agents |
| 03/02/2006 | WO2005063304A3 Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent |
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | US20060046997 6-Alkenyl -, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 03/02/2006 | US20060045846 Reagents and methods for labeling terminal olefins |
| 03/02/2006 | US20060045845 NeuX- a new composition of matter |
| 03/02/2006 | DE19916896B4 Teilchen mit kleiner Dimension, die eine Wand aus einem Gemisch von vernetzten Proteinen und Polysacchariden aufweisen, die an der Oberfläche mit Metallionen chelatbildende Hydroxamgruppen enthalten, Verfahren zu ihrer Herstellung und ihre verschiedenen Verwendungen insbesondere in der kosmetischen, pharmazeutischen und Nahrungsmittelindustrie Particles having smaller dimensions, which have a wall composed of a mixture of cross-linked proteins, and polysaccharides containing on the surface with metal ions chelating hydroxamic groups, process for their preparation and to their different uses, particularly in the cosmetic, pharmaceutical and food industry |
| 03/02/2006 | DE102004023093B3 Trimere makrocyclisch substituierte Halogen-Benzolderivate Trimeric macrocyclic substituted halogen-benzene derivatives |
| 03/02/2006 | CA2573453A1 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 03/01/2006 | EP1628991A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1127355B1 Products and methods for brachytherapy |
| 03/01/2006 | EP0973552B1 Improvements in or relating to diagnostic/therapeutic agents |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 02/28/2006 | USRE38994 Pyropheophorbides conjugates and their use in photodynamic therapy |
| 02/28/2006 | US7005119 Stereoisomers of fatty acid analogs for diagnostic imaging |
| 02/28/2006 | CA2515158A1 Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease |
| 02/23/2006 | WO2006020743A2 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| 02/23/2006 | WO2006020156A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 02/23/2006 | WO2006019114A1 Skin-lightening agent containing polyphenol compound |